US FDA approves Tanzeum to treat type II diabetes
Tanzeum is a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalise blood sugar levels
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Three more cos face US FDA ire-1
Last month, the US FDA has reportedly issued 483s to at least three more pharmaceutical companies in India, one of them the Indian…
Glenmark Generics receives approval for Eszopiclone tablets
Eszopiclone is indicated for the treatment of insomnia
Videojet Technologies to showcase comprehensive product portfolio at Interpack
Collaboration between Videojet and sister company Esko will demonstrate how Esko‘s leading software solution can be leveraged to…
Boehringer Ingelheim sees increase in operating income and return on net sales
Net sales of around €14.1 billion achieved
Pharma industry to get the highest increment this year
Voluntary attrition rate stands at an average of 12.8 per cent, highest attrition rate of 15.6 percent in clerical cadre
Sanofi India appoints N Rajaram as Country Head and General Manager Pharmaceutical Operations
Rajaram will be responsible for driving the company’s ambitious growth plans in the pharma and consumer healthcare segments
Glenmark Pharmaceuticals receives $5 mn from Sanofi
Total Payment received for GBR 500 monoclonal antibody programme from Sanofi is $55 mn
Abbott test could help physicians diagnose people in the US
People with diabetes who can understand and manage their condition can prevent or delay health problems, which may lead to longer…
Intertek organises EL seminar in Mumbai
Seminar focuses on providing detailed information and practical guidance on the issues associated with extractables and leachables…